. Author manuscript; available in PMC: 2019 Jul 31.

Published in final edited form as: Circ Cardiovasc Imaging. 2019 May;12(5):e009018. doi: 10.1161/CIRCIMAGING.119.009018

Table 2.

Odds Ratio (95% CI) for Left Ventricular Alterations at Baseline (2001–2004) and at Follow-Up (2006–2009) Per a 2-Fold Increase in Urinary Arsenic Levels, Among All Participants and by Blood Pressure Status

	Baseline			Follow-Up
	Cases/Noncases	Prevalence OR (95% Cl)		Cases/Noncases	Incidence OR (95% Cl)
	Cases/Noncases	Model 1	Model 2	Cases/Noncases	Model 1	Model 2
LV hypertrophy (LVMI)
All participants	61/1276	1.37 (0.99–1.92)	1.47 (1.05–2.08)	28/1162	0.91 (0.53–1.55)	0.95 (0.58–1.56)
Prehypertension/hypertension	42/622	1.51 (1.02–2.23)	1.58 (1.04–2.41)	23/554	0.85 (0.48–1.54)	0.82 (0.45–1.50)
Normal BP	19/654	1.08 (0.61–1.91)	1.20 (0.64–2.26)	5/608	1.28 (0.68–2.38)	1.20 (0.59–2.43)

Model 1 adjusted for age and sex.

Model 2 additionally adjusted for region, smoking (never, former, current), body mass index (continuous), dyslipidemia (no/yes), fasting glucose level (continuous), estimated glomerular filtration rate (continuous), systolic BP (continuous), and BP treatment (no/yes). BP indicates blood pressure; LV, left ventricular; LVMI, LV mass index; and OR, odds ratio.